Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HITI
HITI logo

HITI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.280
Open
2.280
VWAP
2.28
Vol
7.98K
Mkt Cap
200.34M
Low
2.280
Amount
18.20K
EV/EBITDA(TTM)
7.19
Total Shares
87.87M
EV
379.82M
EV/OCF(TTM)
15.06
P/S(TTM)
0.42
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include bricks-and-mortar, e-commerce and medical cannabis distribution. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries and supports the distribution of accessories and other items to the United States. The medical cannabis distribution segment includes the medical cannabis distribution operations. It offers a suite of proprietary brands which include Dopezilla, Atomik, Puff Puff Pass, Vodka Glass, Queen of Bud, and Cabana Cannabis Co. Canna Cabana is the Company’s primary retail cannabis business, offering the retail sale of various cannabis products and accessories through its provincially authorized cannabis retail store locations. Canna Cabana operates a retail cannabis chain with approximately 219 branded stores operating across Canada.
Show More

Events Timeline

(ET)
2026-06-15
16:30:00
High Tide Reports Q2 Revenue of C$179.3M
select
2026-06-15
06:30:00
High Tide Acquires 100% Equity of Northern Helm for $7.74M
select
2026-04-20 (ET)
2026-04-20
06:10:00
High Tide's Canna Cabana Store to Open on April 20, 2026
select
2026-03-17 (ET)
2026-03-17
19:40:00
Stock Futures Slightly Lower Amid Oil Price Volatility
select
2026-03-17
16:10:00
High Tide Q1 Revenue Reaches $178.3M, Exceeds Expectations
select
2026-03-04 (ET)
2026-03-04
10:10:00
High Tide and NuLeaf Join National Compassionate Care Council as Founding Members
select
2026-02-09 (ET)
2026-02-09
08:10:00
High Tide Opens 219th Canna Cabana Store in Ontario
select

News

PRnewswire
7.5
06-17PRnewswire
High Tide Showcases Medical Cannabis Partnerships in Germany
  • Market Expansion: High Tide's subsidiary Remexian showcased exclusive medical cannabis distribution partnerships with several Canadian brands at the 2026 Mary Jane Berlin trade show, further solidifying its leading position in Germany's rapidly growing medical cannabis market.
  • Diverse Product Portfolio: Remexian highlighted medical cannabis products from brands like Tribal and Highly Dutch Organic, emphasizing its expanding portfolio of exclusive distribution agreements that connect directly with pharmacies and healthcare professionals in Germany, addressing patient demand for high-quality products.
  • Positive Industry Response: The event garnered positive feedback from patients and healthcare professionals, indicating a rising demand for high-quality, trusted cannabis products, which enhances Remexian's competitive edge in the market.
  • Strategic Investment: By continuously broadening its product offerings and strengthening supply chain relationships, Remexian aims to capture a larger share of one of the world's most attractive medical cannabis markets, showcasing High Tide's strategy of leveraging its Canadian strengths for global diversification.
Newsfilter
7.5
06-17Newsfilter
High Tide Showcases Medical Cannabis Partnerships in Germany
  • Market Expansion: High Tide's subsidiary Remexian showcased exclusive medical cannabis distribution partnerships with several Canadian brands at the 2026 Mary Jane Berlin trade show, further solidifying its leading position in Germany's rapidly growing medical cannabis market.
  • Diverse Product Portfolio: Remexian highlighted medical cannabis products from brands like Tribal and Highly Dutch Organic, emphasizing its expanding portfolio of exclusive distribution agreements that connect Canadian brands directly with pharmacies and healthcare professionals in Germany.
  • Industry Opportunities: Germany is viewed as a significant growth opportunity in the global medical cannabis industry, and Remexian's participation not only enhances its reputation as a trusted importer of premium products but also fosters relationships with healthcare professionals, facilitating the expansion of its pharmacy network.
  • Competitive Advantage: High Tide's CEO Raj Grover stated that by continuously broadening its product offerings and strengthening supply chain relationships, Remexian is positioning itself to capture a larger share of one of the world's most attractive medical cannabis markets, showcasing its unique procurement capabilities and market strategy.
Yahoo Finance
9.5
06-16Yahoo Finance
High Tide Inc Reports Record Q2 Earnings with 30% Revenue Growth
  • Significant Revenue Growth: High Tide Inc reported a record revenue of $179.3 million in Q2, reflecting a 30% year-over-year increase, marking the fastest growth rate in 11 quarters and indicating strong market performance and expansion potential.
  • Record Gross Margin: The company achieved a gross profit of $48.4 million with a gross margin of 27%, the highest in eight quarters, showcasing improved profitability in its medical cannabis distribution segment, particularly in the German market.
  • Strong Membership Growth: Cabana Club membership reached 2.65 million, up 39% year-over-year, with elite memberships soaring by 84%, which not only enhances customer loyalty but also lays a solid foundation for future sales growth.
  • Enhanced Financial Flexibility: High Tide secured a $40 million credit facility with Bank of Montreal, boosting its financial flexibility; despite free cash flow being $1.5 million, the company is actively investing to support future expansion plans.
seekingalpha
9.5
06-16seekingalpha
High Tide Reports Q2 Earnings Beat, Shares Surge 21%
  • Record Revenue: High Tide reported a record revenue of C$179.3 million for Q2 FY2026, reflecting a 30% year-over-year increase and surpassing estimates of C$171.15 million, indicating strong performance in the retail sector.
  • Stable Market Share: Canna Cabana maintained a 12% market share, and excluding British Columbia's restrictions, its share increased to 14%, up from 13% last year, demonstrating robust growth in a competitive market.
  • Improved Profitability: Adjusted EBITDA reached a record C$13.9 million, a 73% year-over-year increase and the fastest growth in nine quarters, despite having three fewer days in the quarter, showcasing effective cost control and operational efficiency.
  • Medical Cannabis Distribution Growth: Remexian achieved a record distribution of 7.6 tonnes of medical cannabis in Germany, marking a 49% year-over-year and 21% sequential increase, further solidifying High Tide's position in the international market.
PRnewswire
9.5
06-15PRnewswire
High Tide Reports Strong Q2 Results with Record Revenue
  • Record Revenue: High Tide's German medical cannabis subsidiary, Remexian Pharma GmbH, achieved record revenue of $31.6 million in Q2 2026, demonstrating strong growth potential in the medical cannabis market and further solidifying its market position.
  • Margin Improvement: Remexian's gross margins increased to 27%, reflecting effective cost control and successful strategies in product pricing and market demand, thereby enhancing overall profitability.
  • Positive Free Cash Flow: The company reported positive free cash flow, indicating strong operational efficiency and financial health, which provides funding support for future expansions and investments, boosting investor confidence.
  • Financial Transparency: High Tide released unaudited financial statements for the period ending April 30, 2026, ensuring financial transparency and enhancing market trust in its long-term growth strategy.
Newsfilter
9.5
06-15Newsfilter
High Tide Reports Record Revenue and Growth in Q2 2026
  • Record Revenue: High Tide achieved a record revenue of CAD 179.3 million in Q2 2026, reflecting a 30% year-over-year increase, marking the fastest growth rate in 11 quarters and demonstrating strong performance in both Canadian and German markets.
  • Medical Cannabis Growth: Remexian Pharma GmbH generated record revenue of CAD 31.6 million from medical cannabis sales in Germany, with gross margins increasing to 27%, indicating that the company's market share has now exceeded 14%, laying a solid foundation for future expansion.
  • Positive Free Cash Flow: Although free cash flow was CAD 1.5 million, down from CAD 4.9 million last year, the company reported strong operating cash flow of CAD 8.8 million, showcasing its ongoing financial health and growth potential.
  • Significant Membership Growth: Cabana Club membership has surpassed 2.65 million, up 39% year-over-year, while ELITE membership reached 178,000, an 84% increase, indicating continued improvement in customer loyalty and market share.
Wall Street analysts forecast HITI stock price to rise
1 Analyst Rating
Wall Street analysts forecast HITI stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
7.50
Averages
7.50
High
7.50
Current: 0.000
sliders
Low
7.50
Averages
7.50
High
7.50
Canaccord
Buy
maintain
$7
AI Analysis
2026-03-19
Reason
Canaccord
Price Target
$7
AI Analysis
2026-03-19
maintain
Buy
Reason
Canaccord raised the firm's price target on High Tide to C$7.25 from C$7 and keeps a Buy rating on the shares.
TD Securities
NULL
to
Buy
initiated
$6.50
2026-02-24
Reason
TD Securities
Price Target
$6.50
2026-02-24
initiated
NULL
to
Buy
Reason
TD Securities initiated coverage of High Tide with a Buy rating and C$6.50 price target. The cannabis retailer has leading key performance indicators, including market share, same-store sales growth, store economics, and a rapidly growing 2.5M member loyalty program, says the analyst, who calls High Tide the firm's top cannabis pick.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HITI
Unlock Now

Valuation Metrics

The current forward P/E ratio for High Tide Inc (HITI.O) is 46.30, compared to its 5-year average forward P/E of 21.55. For a more detailed relative valuation and DCF analysis to assess High Tide Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
21.55
Current PE
46.30
Overvalued PE
287.65
Undervalued PE
-244.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.90
Current EV/EBITDA
5.05
Overvalued EV/EBITDA
23.82
Undervalued EV/EBITDA
-2.01

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.52
Current PS
0.25
Overvalued PS
0.88
Undervalued PS
0.16

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what stock under $5 should I buy today?
Intellectia · 56 candidates
Market Cap: >= 100.00MRegion: USPrice: $0.50 - $5.00Quarter Revenue Yoy Growth: >= 5.0%List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
API logo
API
Agora Inc
431.16M
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.58B
GOGO logo
GOGO
Gogo Inc
599.67M
IMPP logo
IMPP
Imperial Petroleum Inc
188.03M
OCGN logo
OCGN
Ocugen Inc
608.82M
TRON logo
TRON
TRON Inc
359.44M
bullish signal / value surage stock under 3$
Intellectia · 68 candidates
Price: <= $3.00Relative Vol: >= 1.20Moving Average Relationship: PriceCrossAboveMA5Week Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
OPK logo
OPK
OPKO Health Inc
1.06B
SES logo
SES
SES AI Corp
861.57M
AMC logo
AMC
AMC Entertainment Holdings Inc
825.84M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
NFE logo
NFE
New Fortress Energy Inc
441.06M

Whales Holding HITI

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is High Tide Inc (HITI) stock price today?

The current price of HITI is 2.28 USD — it has increased 0

What is High Tide Inc (HITI)'s business?

High Tide Inc. is a retail-focused cannabis company. The Company’s segments include bricks-and-mortar, e-commerce and medical cannabis distribution. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries and supports the distribution of accessories and other items to the United States. The medical cannabis distribution segment includes the medical cannabis distribution operations. It offers a suite of proprietary brands which include Dopezilla, Atomik, Puff Puff Pass, Vodka Glass, Queen of Bud, and Cabana Cannabis Co. Canna Cabana is the Company’s primary retail cannabis business, offering the retail sale of various cannabis products and accessories through its provincially authorized cannabis retail store locations. Canna Cabana operates a retail cannabis chain with approximately 219 branded stores operating across Canada.

What is the price predicton of HITI Stock?

Wall Street analysts forecast HITI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HITI is7.50 USD with a low forecast of 7.50 USD and a high forecast of 7.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is High Tide Inc (HITI)'s revenue for the last quarter?

High Tide Inc revenue for the last quarter amounts to 179.30M USD, increased 30.11

What is High Tide Inc (HITI)'s earnings per share (EPS) for the last quarter?

High Tide Inc. EPS for the last quarter amounts to -0.00 USD, decreased -100.00

How many employees does High Tide Inc (HITI). have?

High Tide Inc (HITI) has 1832 emplpoyees as of July 01 2026.

What is High Tide Inc (HITI) market cap?

Today HITI has the market capitalization of 200.34M USD.